Buy Cadila Healthcare, target Rs 325: Manas Jaiswal

Manas Jaiswal of manasjaiswal.com has a buy call on Cadila Healthcare Ltd. with a target price of Rs 325.0 . The current market price of Cadila Healthcare Ltd. is Rs 343.3 Time period given by analyst is Intra Day when Cadila Healthcare Ltd. price can reach defined target. Manas Jaiswal recommended to keep stoploss at Rs 356. Cadila Healthcare Ltd., incorporated in 1995, is a largecap company with a market cap of Rs 35145.08 crore.

Cadila Healthcare Ltd. key Products/Revenue Segments include Pharmaceutical Products which contributed Rs 3098.00 Crore to Sales Value (94.60 % of Total Sales), Export Incentives which contributed Rs 85.00 Crore to Sales Value (2.59 % of Total Sales), Other Operating Revenue which contributed Rs 82.10 Crore to Sales Value (2.50 % of Total Sales) and Royalty Income which contributed Rs 9.40 Crore to Sales Value (0.28 % of Total Sales)for the year ending 31-Mar-2017.

For the quarter ended 31-03-2018, the company has reported a Consolidated sales of Rs 3152.70 Crore, down -1.23 % from last quarter Sales of Rs 3191.80 Crore and up 30.41 % from last year same quarter Sales of Rs 2417.50 Crore Company has reported net profit after tax of Rs 579.60 Crore in latest quarter. The company’s top management includes Dr.Sharvil P Patel, Mr.Apurva S Diwanji, Mr.Ganesh N Nayak, Mr.Humayun R Dhanrajgir, Mr.Mukesh M Patel, Mr.Nitin R Desai, Mr.Pankaj R Patel, Ms.Dharmishta N Rawal. Company has Mukesh M Shah & Co. as its auditoRs As on 30-06-2018, the company has a total of 1,023,742,600 shares outstanding.